Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... in chronic phase, accelerated phase or blast crisis; Acute Myelogenous Leukemia (AML);Myelodysplastic Syndrome (MDS); Juvenile ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  2. Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

    ... One of the following disease categories: Acute myelogenous leukemia - high risk CR1 (as evidenced by preceding MDS, ...

    Clinical Trial last updated 04/29/2016 - 1:48pm.

  3. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... must have one of the following hematologic malignancies: Acute Myelogenous Leukemia (AML), induction failure, high-risk for relapse first ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  4. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... Disease Criteria (standard risk patients) Acute myelogenous leukemia Acute lymphocytic leukemia Chronic myelogenous ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  5. Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS

    ... transplantation will be given to patients with high risk acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). ...

    Clinical Trial last updated 04/28/2016 - 11:08am.

  6. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... (transfusion dependent) or myelodysplastic syndrome, or acute myelogenous leukemia for whom an allogeneic stem cell transplant is ...

    Clinical Trial last updated 04/28/2016 - 8:44am.

  7. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... must have one of the following hematologic malignancies: Acute Myelogenous Leukemia (AML), induction failure, high-risk for relapse first ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  8. Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

    ... of neutrophils and platelets, low incidences of acute and chronic graft versus host disease, low frequency of delayed ... or cytologically confirmed diagnosis of: Acute Myelogenous Leukemia Myelodysplastic Syndrome Acute Lymphocytic Leukemia Lymphoma ...

    Clinical Trial last updated 04/29/2016 - 1:15pm.

  9. James M. Rossetti, DO

    ... with particular interest in myeloid malignancy, acute myelogenous leukemia , myelodysplasia, and cellular therapy. He is ...

    Bio last updated 03/11/2016 - 1:41pm.

  10. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... Syndrome (MDS) (based on WHO or IPSS Classification Acute Myelogenous Leukemia (untreated, in remission or with refractory or ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.